» Articles » PMID: 26878873

MiR-193b Promotes Autophagy and Non-apoptotic Cell Death in Oesophageal Cancer Cells

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2016 Feb 17
PMID 26878873
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Successful treatment of oesophageal cancer is hampered by recurrent drug resistant disease. We have previously demonstrated the importance of apoptosis and autophagy for the recovery of oesophageal cancer cells following drug treatment. When apoptosis (with autophagy) is induced, these cells are chemosensitive and will not recover following chemotherapy treatment. In contrast, when cancer cells exhibit only autophagy and limited Type II cell death, they are chemoresistant and recover following drug withdrawal.

Methods: MicroRNA (miRNA) expression profiling of an oesophageal cancer cell line panel was used to identify miRNAs that were important in the regulation of apoptosis and autophagy. The effects of miRNA overexpression on cell death mechanisms and recovery were assessed in the chemoresistant (autophagy inducing) KYSE450 oesophageal cancer cells.

Results: MiR-193b was the most differentially expressed miRNA between the chemosensitive and chemoresistant cell lines with higher expression in chemosensitive apoptosis inducing cell lines. Colony formation assays showed that overexpression of miR-193b significantly impedes the ability of KYSE450 cells to recover following 5-fluorouracil (5-FU) treatment. The critical mRNA targets of miR-193b are unknown but target prediction and siRNA data analysis suggest that it may mediate some of its effects through stathmin 1 regulation. Apoptosis was not involved in the enhanced cytotoxicity. Overexpression of miR-193b in these cells induced autophagic flux and non-apoptotic cell death.

Conclusion: These results highlight the importance of miR-193b in determining oesophageal cancer cell viability and demonstrate an enhancement of chemotoxicity that is independent of apoptosis induction.

Citing Articles

Autophagy and its role in gastrointestinal diseases.

Shao B, Zhang W, Liu Z, Linghu E World J Gastroenterol. 2024; 30(36):4014-4020.

PMID: 39351250 PMC: 11439115. DOI: 10.3748/wjg.v30.i36.4014.


Cordycepin from Cordyceps militaris ameliorates diabetic nephropathy via the miR-193b-5p/MCL-1 axis.

Zheng R, Zhang W, Song J, Zhong Y, Zhu R Chin Med. 2023; 18(1):134.

PMID: 37833817 PMC: 10576278. DOI: 10.1186/s13020-023-00842-5.


Effect of paclitaxel treatment on cellular mechanics and morphology of human oesophageal squamous cell carcinoma in 2D and 3D environments.

Kiwanuka M, Higgins G, Ngcobo S, Nagawa J, Lang D, Zaman M Integr Biol (Camb). 2022; .

PMID: 36244059 PMC: 9585394. DOI: 10.1093/intbio/zyac013.


Autophagy in gastrointestinal cancers.

Shao B, Chai N, Yao Y, Li J, Law H, Linghu E Front Oncol. 2022; 12:975758.

PMID: 36091106 PMC: 9459114. DOI: 10.3389/fonc.2022.975758.


Virus, Exosome, and MicroRNA: New Insights into Autophagy.

Nahand J, Salmaninejad A, Mollazadeh S, Tamehri Zadeh S, Rezaee M, Sheida A Adv Exp Med Biol. 2022; 1401:97-162.

PMID: 35781219 DOI: 10.1007/5584_2022_715.


References
1.
Yang W, Lee D, Ben-David Y . The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol. 2011; 3(2):140-55. PMC: 3134008. View

2.
Frankel L, Wen J, Lees M, Hoyer-Hansen M, Farkas T, Krogh A . microRNA-101 is a potent inhibitor of autophagy. EMBO J. 2011; 30(22):4628-41. PMC: 3243595. DOI: 10.1038/emboj.2011.331. View

3.
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L . HMGB1 in health and disease. Mol Aspects Med. 2014; 40:1-116. PMC: 4254084. DOI: 10.1016/j.mam.2014.05.001. View

4.
Akhtar J, Wang Z, Jiang W, Bi M, Zhang Z . Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol. 2013; 29(5):944-50. DOI: 10.1111/jgh.12498. View

5.
Solomon V, Lee H . Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol. 2009; 625(1-3):220-33. DOI: 10.1016/j.ejphar.2009.06.063. View